PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.04%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.64%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-18.51%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.97%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-19.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.21%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-19.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Reduced diluted shares while ADI is at 0.49%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
4.88%
Dividend growth above 1.5x ADI's 0.02%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-0.67%
Negative OCF growth while ADI is at 3.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
75.57%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
61.04%
10Y revenue/share CAGR under 50% of ADI's 151.67%. Michael Burry would suspect a lasting competitive disadvantage.
15.12%
5Y revenue/share CAGR at 50-75% of ADI's 26.20%. Martin Whitman would worry about a lagging mid-term growth trajectory.
1.24%
3Y revenue/share CAGR under 50% of ADI's 32.22%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
91.92%
10Y OCF/share CAGR at 50-75% of ADI's 164.35%. Martin Whitman might fear a structural deficiency in operational efficiency.
-5.86%
Negative 5Y OCF/share CAGR while ADI is at 23.27%. Joel Greenblatt would question the firm’s operational model or cost structure.
-8.36%
Negative 3Y OCF/share CAGR while ADI stands at 31.14%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
220.89%
Net income/share CAGR above 1.5x ADI's 55.36% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
16.14%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
-17.80%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
87.00%
Below 50% of ADI's 371.43%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
97.18%
5Y equity/share CAGR at 50-75% of ADI's 140.07%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
86.15%
3Y equity/share CAGR at 50-75% of ADI's 120.22%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
333.29%
10Y dividend/share CAGR above 1.5x ADI's 153.81%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
68.41%
5Y dividend/share CAGR at 75-90% of ADI's 76.94%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
27.57%
3Y dividend/share CAGR at 50-75% of ADI's 38.48%. Martin Whitman might see a weaker short-term approach to distributing cash.
-9.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.33%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.24%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.60%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
5.05%
Debt growth far above ADI's 8.94%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-2.34%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.10%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.